RIG
BIIB icon

RiverFront Investment Group’s Biogen BIIB Stock Holding History

RiverFront Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-935
Closed -$324K – 89
2021
Q2 		$324K Buy
935
+83
+10% +$25.1K 0.01% 79
2021
Q1 		$238K Buy
852
+32
+4% +$8.63K 0.01% 104
2020
Q4 		$201K Buy
+820
New +$212K ﹤0.01% 112

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RiverFront Investment Group's BIIB Position: Q3 2021 in Review

RiverFront Investment Group sold out of Biogen (BIIB) in Q3 2021, closing a stake of 935 shares — an estimated $324K sold.

RiverFront Investment Group first reported a position in BIIB in Q4 2020 and held it in 3 quarters. The position peaked at $324K in Q2 2021. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • RiverFront Investment Group reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • RiverFront Investment Group sold 935 Biogen shares in Q3 2021, an estimated $324K.
  • RiverFront Investment Group first reported a position in Biogen in Q4 2020 and held it in 3 quarters.
  • RiverFront Investment Group's Biogen position peaked at $324K in Q2 2021.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on RiverFront Investment Group's 13F filing for Q3 2021, filed 2 Nov 2021.